Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Genome Biology
|
October 24, 2025
Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response
Alexandre Devaux, Iris Tanaka, Quentin Fouilleul, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Alice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
Frontiers in Genetics
|
June 10, 2014
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
Nicolas Servant, Julien Roméjon, Pierre Gestraud, et al.
British Journal of Cancer
|
August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
NPJ Precision Oncology
|
July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
British Journal of Cancer
|
September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
Ebiomedicine
|
October 23, 2020
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
Suzy M Scholl, Jonas Beal, Leanne de Koning, et al.
Molecular Oncology
|
August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial
Célia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
EMBO Molecular Medicine
|
September 7, 2022
A catalog of numerical centrosome defects in epithelial ovarian cancers
Jean-Philippe Morretton, Anthony Simon, Aurélie Herbette, et al.
The Lancet Regional Health. Europe
|
November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Genome Biology
|
October 24, 2025
Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response
Alexandre Devaux, Iris Tanaka, Quentin Fouilleul, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Alice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
Frontiers in Genetics
|
June 10, 2014
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
Nicolas Servant, Julien Roméjon, Pierre Gestraud, et al.
British Journal of Cancer
|
August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
NPJ Precision Oncology
|
July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
British Journal of Cancer
|
September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
Ebiomedicine
|
October 23, 2020
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
Suzy M Scholl, Jonas Beal, Leanne de Koning, et al.
Molecular Oncology
|
August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial
Célia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
EMBO Molecular Medicine
|
September 7, 2022
A catalog of numerical centrosome defects in epithelial ovarian cancers
Jean-Philippe Morretton, Anthony Simon, Aurélie Herbette, et al.
The Lancet Regional Health. Europe
|
November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Page
of 4